Skip to content

Performance and Safety of Lubri-cream for Pain Minimization During Urethral Catheterization and Cystoscopy

Performance and Safety of Lubri-cream for Pain Minimization During Urethral Catheterization and Cystoscopy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06101121
Enrollment
120
Registered
2023-10-26
Start date
2023-12-31
Completion date
2024-10-31
Last updated
2023-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urethral Catheter; Complications

Brief summary

The primary aim of this study is to collect clinical data on the performance of Lubri-cream applied in routine clinical practice. Safety and efficacy parameters of Lubri-cream in lubrication on bladder catheterization and cystoscopy will be assessed.

Detailed description

The study is designed as a prospective, multicenter, single-group, observational study to evaluate Lubri-cream for urethral catheterization and cystoscopies lubrication. At least 2 different centers located in Spain will participate. It is primarily aimed to collect data on the performance of the product under investigation in a large patient population when used in routine clinical practice. Safety and performance of Lubri-cream will be assessed to study the pain minimization when patients undergo urethral catheterization and cystoscopy procedures.

Interventions

DEVICELubri-Cream

Lubri-cream is indicated as a surface lubricant for bladder catheterization and cystoscopy. It will be slowly applied on the device, exerting gentle and constant pressure on the tube. Its contents will be evenly distrubuted from the tip to a suitable distance according to the technique to be performed. An individualized dose will be applied according to the technique to be performed and at the discretion of the healthcare professional

Sponsors

B. Braun Medical SA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Any patient who needs urethral catheterization or cystoscopy (rigid or flexible). * Signed informed consent

Exclusion criteria

* Contraindications as stated in the Instructions for Use * Any medical or psychological disorder that, in the investigator's opinion, may interfere with the patient's ability to give informed consent and comply with the study procedures * Inclusion in another investigational study in the field of urethral catheterization or cystoscopy which could interfere with the clinical practice regarding the application and care of the Investigational Product.

Design outcomes

Primary

MeasureTime frameDescription
Performance of Lubri-cream based on the pain minimization when patients undergo urethral catheterization and cystoscopy procedures.During catheter insertion, catheter removal and if any complication appears (AE/SAEs)Patients' perception of pain level will be measured using the VAS, a visual scale of 10 cm in length, anchored by word descriptors at each end where 0 cm means no pain and 10 cm means worst ever pain. The zero-end will be marked with no pain and the 10 cm-end will be marked as worst ever pain.

Secondary

MeasureTime frameDescription
Safety of Lubri-cream based on routinely measured clinical parametersDuring catheter insertion and catheter removalOccurrence of adverse events after its use in patients

Contacts

Primary ContactAina Fernández
aina.fernandez@bbraun.com+34 663 895 945
Backup ContactJoan LLuís Pérez
joan_lluis.perez@bbraun.com+34 670 528 799

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026